ABBOTT INDIA LIMITED

Tivic Health completes enrolment in a study to optimize its non-invasive vagus nerve stimulation (VNS) device, aiming to address clinical indications not well-served by current options. Conducted at Northwell Health’s Feinstein Institute, the study seeks optimal device parameters for influencing the autonomic nervous system. Tivic expects results to guide further testing and commercial development, with the trial anticipated to conclude in early 2025.

A two-arm cluster-randomized controlled trial in Zambia evaluated malaria vector control using attractive targeted sugar baits (ATSB). The trial included 70 clusters with a 'fried egg' design to prevent contamination. Participants were children aged 1–14 years, with primary outcomes of symptomatic malaria incidence and secondary outcomes of infection prevalence. The trial also monitored adverse events related to ATSB exposure and artemether lumefantrine (AL) use. Statistical analyses included generalized linear models and Cox proportional hazards models.

The Biotechnology Reagents Market is projected to reach USD 1.07 billion by 2031, driven by rising R&D investments and technological advancements. Key players include Abbott, Agilent Technologies, Danaher, and Bio-Rad Laboratories. The market is expected to grow at a CAGR of 12.20% from 2022 to 2029, with North America leading in adoption.

Cadrenal Therapeutics presented tecarfarin data and proposed clinical trial protocol at the 8th EACTS Mechanical Circulatory Support Summit, aiming to evaluate tecarfarin versus warfarin in Abbott HeartMate3 LVAD patients, with potential to improve time in therapeutic range (TTR) and reduce bleeding events.

By 2025, all nine private hospitals in Singapore will contribute patient health records to the National Electronic Health Record (NEHR) to reduce errors and unnecessary tests. A new Health Information Bill will mandate nationwide data contribution to NEHR, ensuring safe collection and sharing of health information. Patients can opt out of data sharing, and Healthier SG participants will receive personalized health plans. Technology and wearables are also being used to improve patient health.

SEC recommends market authorisation for MSN Laboratories' generic Pitolisant tablets for narcolepsy, with conditions including a phase-IV trial. The drug, a generic of Harmony Biosciences' Wakix, addresses EDS and cataplexy, with a novel mechanism and unmet need. MSN must include CYP2D6 Genotype determination in prescribing info. Harmony Biosciences holds a US patent until 2029 and sued MSN for patent infringement.

Celebrating the 20th anniversary of Singapore Population Health Studies (SPHS), the article highlights the contributions of Saw Swee Hock School of Public Health, volunteers, and technology in advancing population health initiatives like Healthier SG and Age Well SG. It discusses the development of personalized health plans, leveraging wearables and health apps, and the importance of a centralized National Electronic Health Record (NEHR) system for seamless healthcare delivery and research. The article concludes with the promise of transforming healthcare through data availability and research empowerment.

ClearPoint Neuro reports Q3 2024 record revenues of $8.1 million, up 41% YoY, driven by growth in Biologics and Drug Delivery and Neurosurgery Navigation segments. The company anticipates FDA approvals for gene therapy products and expansion in the neurosurgery market.

The heart's tricuspid valve can fail, causing tricuspid regurgitation, diagnosed via echocardiogram. Treatment isn't always necessary, but the TriClip G4, similar to the MitraClip™, can reduce severe leakage in symptomatic patients, especially those unsuitable for surgery.

The Microfluidics Market was valued at USD 27.86 Billion in 2023 and is projected to reach USD 92.43 Billion by 2032, growing at a CAGR of 14.29%. Driven by diagnostics, personalized medicine, and AI integration, microfluidics technologies like lab-on-a-chip and point-of-care systems are revolutionizing healthcare. Key players include Illumina, F. Hoffmann-La Roche, PerkinElmer, and Agilent Technologies. Applications extend to environmental monitoring, wearable health devices, and food safety testing, with North America leading the market and Asia-Pacific showing strong growth potential.